- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease ; volume:9 ; number:1 ; day:28 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (28.2.2019), 1-10, 12.2019
- Urheber
-
Lee, Chi Fung
Caudal, Arianne
Abell, Lauren
Nagana Gowda, G. A.
Tian, Rong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39419-4
- URN
-
urn:nbn:de:101:1-2019032022053341937107
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Chi Fung
- Caudal, Arianne
- Abell, Lauren
- Nagana Gowda, G. A.
- Tian, Rong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism
Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism
Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism